Showing 1 - 10 of 12
Pfizer buys biotech firm Seagen for $43 billion
AFP, Published on 13/03/2023
» WASHINGTON - US pharmaceutical giant Pfizer announced Monday that it had reached a deal to buy biotech firm Seagen, specializing in innovative cancer treatment, for $43 billion.
Testament to protecting millions of lives
Business, Janine Phakdeetham, Published on 24/03/2022
» The race against time to safely develop and quickly deliver a life-saving COVID-19 vaccine around the world serves as AstraZeneca's testament to protecting the lives of billions of people while addressing one of the biggest healthcare crises facing humankind.
Drugmakers Reap Billions Meeting Covid-19 Needs
Business, Peter Loftus, Published on 28/02/2022
» Healthcare companies that came up with effective Covid-19 vaccines, treatments and tests are seeing a huge financial payoff and are starting to spend their cash, while grappling with questions about whether the growth is sustainable.
Foreign Executives in Isolated Hong Kong Head for the Exit
Business, Dan Strumpf, Published on 25/01/2022
» Stringent rules to try to keep Hong Kong free of Covid-19 are driving away more foreign executives, chipping away at the city's decades-old status as one of the world's top business hubs.
Reopening faces more hurdles
Business, Narumon Kasemsuk, Lamonphet Apisitniran and Dusida Worrachaddejchai, Published on 27/09/2021
» Prime Minister Prayut Chan-o-cha's vow on June 16 to reopen Thailand by mid-October can be deemed a failure as only a few islands are welcoming vaccinated foreigners.
Quarantine Rules Threaten Hong Kong's Role as Finance Hub, Businesses Say
Business, Elaine Yu, Published on 30/08/2021
» In an effort to maintain zero locally transmitted Covid-19 cases, Hong Kong has imposed one of the world's toughest quarantine regimes, confining most arrivals from overseas to a hotel room for as long as three weeks.
Vaccine race
Asia focus, Ismira Lutfia Tisnadibrata, Published on 17/08/2020
» Human trials of a potential Covid-19 vaccine developed by Sinovac Biotech of China are under way in Indonesia, with two groups of volunteers receiving their first injections last week.
New China-US spat takes shine off stocks
Business, Nuntawun Polkuamdee & Darana Chudasri, Published on 25/07/2020
» Recap: Global shares ended the week on a downbeat note despite a bounceback in European business activity as concerns flared over intensifying China-US tensions, while gold approached its all-time high of US$1,920 per ounce.
A new direction for biopharma in China
Asia focus, Suwatchai Songwanich, Published on 04/05/2020
» While many industries will be in recovery mode for some time to come, one sector that can expect strong growth in China is the biotech and biopharmaceutical industries.
Vaccines in development hit 70, deaths top 114,000: Virus update
Bloomberg News, Published on 13/04/2020
» Seventy coronavirus vaccines are in development globally, with three already being tested in human trials, the World Health Organization said. The northeastern Chinese city of Harbin tightened rules to curb the spread of the virus.